Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01323
|
|||||
| Drug Name |
Albendazole
|
|||||
| Synonyms |
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle; ((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]; (5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester; (5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester; 5-(Propylthio)-2-carbomethoxyaminobenzimidazole; Albendazol; Albendazol [INN-Spanish]; Albendazole (JAN/USP/INN); Albendazole Armstrong Brand; Albendazole Diba Brand; Albendazole Fustery Brand; Albendazole Hormona Brand; Albendazole Liferpal Brand; Albendazole Monohydrochloride; Albendazole Noe-Socopharm Brand; Albendazole Pfizer Brand; Albendazole Sanicoopa Brand; Albendazole Valdecasas Brand; Albendazole [USAN:INN:BAN:JAN]; Albendazolum; Albendazolum [INN-Latin]; Albendoral; Albenza; Albenza (TN); Albenza, Eskazole, Zentel, Andazol, Albendazole; Armstrong Brand of Albendazole; Bendapar; Bilutac; CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER; Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester; Diba Brand of Albendazole; Digezanol; Disthelm; Disthelm, Mediamix V; Endoplus; Eskazole; Eskazole (TN); Fustery Brand of Albendazole; Gascop; Hormona Brand of Albendazole; Liferpal Brand of Albendazole; Lurdex; Mediamix V Disthelm; Methyl 5-(propyl-thio)-2-benzimidazolecarbamate; Methyl 5-(propylthio)-2-benzimidazolecarbamate; Methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate; Methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate; Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate; Methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate; Methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate; Methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate; Methyl-5-[propylthio]-2-benzimidazole carbamate; MethylN-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate; Metiazol; Monohydrochloride, Albendazole; Noe Socopharm Brand of Albendazole; Noe-Socopharm Brand of Albendazole; O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate; Pfizer Brand of Albendazole; Proftril; SK&F 62979; SK&F-62979; SK&F62979; SKF 62979; SKF-62979; SKF62979; Sanicoopa Brand of Albendazole; Smith Kline & French Brand of Albendazole; SmithKline Beecham Brand of Albendazole; V Disthelm, Mediamix; Valbazen; Valdecasas Brand of Albendazole; Zental; Zentel; Zentel (TN); [5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester; [5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Parasitic worm infestations [ICD11: 1F90] | Approved | [1] | |||
| Therapeutic Class |
Antiprotozoal Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C12H15N3O2S
|
|||||
| Canonical SMILES |
CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC
|
|||||
| InChI |
InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
|
|||||
| InChIKey |
HXHWSAZORRCQMX-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 54965-21-8
|
|||||
| Pharmaceutical Properties | Molecular Weight | 265.33 | Topological Polar Surface Area | 92.3 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
2.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
4909
, 129996
, 603014
, 855809
, 3154181
, 5010055
, 5590332
, 6318023
, 7847202
, 7978654
, 8144956
, 8150054
, 8151416
, 10321635
, 10589336
, 11112790
, 11242363
, 11335879
, 11361118
, 11364426
, 11366988
, 11369550
, 11373940
, 11377712
, 11462090
, 11466275
, 11467395
, 11485989
, 11492016
, 11495346
, 11521860
, 11528637
, 12014008
, 14823901
, 16704067
, 24890894
, 25623359
, 25751296
, 26612535
, 26679872
, 26746999
, 26747000
, 26751522
, 29221262
, 46506472
, 47216788
, 47291149
, 47296872
, 47296873
, 47742180
|
|||||
| ChEBI ID |
ChEBI:16664
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Albendazole was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | The anthelminthic agent albendazole does not interact with p-glycoprotein. Drug Metab Dispos. 2002 Apr;30(4):365-9. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.